[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 223
1. Quattrocchi CC, Santini D, Dell'aia P, Piciucchi S, Leoncini E, Vincenzi B, Grasso RF, Tonini G, Zobel BB: A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid. Skeletal Radiol; 2007 Dec;36(12):1121-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All patients underwent CT of the chest, abdomen, and pelvis.
  • CONCLUSION: Bone density measured by CT increases at metastatic sites after zoledronic acid treatment, regardless of the type of metastasis, in contrast to apparently normal bone.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):264-72 [17084550.001]
  • [Cites] Radiol Med. 2007 Oct;112(7):1049-59 [17952675.001]
  • [Cites] Radiother Oncol. 2004 Mar;70(3):291-4 [15064015.001]
  • [Cites] Lancet. 1992 Oct 31;340(8827):1049-52 [1357451.001]
  • [Cites] J Orthop Res. 2004 Nov;22(6):1161-7 [15475192.001]
  • [Cites] N Engl J Med. 2004 Jul 8;351(2):195-6; author reply 195-6 [15247365.001]
  • [Cites] Cancer Treat Rev. 1996 Jul;22(4):265-87 [9025784.001]
  • [Cites] Clin Cancer Res. 2003 Jul;9(7):2394-9 [12855610.001]
  • [Cites] Cancer Invest. 1999;17(8):566-74 [10592763.001]
  • [Cites] Anticancer Res. 2002 Mar-Apr;22(2B):1279-88 [12168938.001]
  • [Cites] J Clin Oncol. 1993 Jan;11(1):59-65 [8418243.001]
  • [Cites] J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):169-80 [16025223.001]
  • [Cites] J Clin Oncol. 2004 Jul 15;22(14):2942-53 [15254062.001]
  • [Cites] Br J Urol. 1991 Jul;68(1):74-80 [1873694.001]
  • [Cites] Radiology. 1978 Aug;128(2):371-5 [663247.001]
  • [Cites] Cancer Res. 2002 Feb 1;62(3):917-23 [11830552.001]
  • [Cites] J Bone Miner Res. 2004 Jan;19(1):147-54 [14753746.001]
  • [Cites] BJU Int. 2005 Nov;96(7):964-9 [16225510.001]
  • [Cites] Am J Clin Oncol. 1982 Dec;5(6):649-55 [7165009.001]
  • [Cites] J Natl Cancer Inst. 2005 Jan 5;97(1):59-69 [15632381.001]
  • [Cites] Cancer. 2003 Oct 15;98(8):1735-44 [14534891.001]
  • [Cites] Br J Cancer. 1994 Sep;70(3):554-8 [8080746.001]
  • [Cites] Radiology. 2007 Mar;242(3):811-6 [17325068.001]
  • [Cites] J Bone Miner Res. 1998 Apr;13(4):581-9 [9556058.001]
  • [Cites] N Engl J Med. 1996 Feb 22;334(8):488-93 [8559201.001]
  • [Cites] Cancer J. 2001 Sep-Oct;7(5):377-87 [11693896.001]
  • [Cites] Haematologica. 2006 Dec;91(12):1720-1 [17145616.001]
  • [Cites] Br J Cancer. 1977 Mar;35(3):292-8 [856236.001]
  • [Cites] Cancer. 2000 Jun 15;88(12 Suppl):3033-7 [10898348.001]
  • [Cites] J Clin Oncol. 2005 May 20;23(15):3314-21 [15738536.001]
  • [Cites] Cancer. 1997 Oct 15;80(8 Suppl):1546-56 [9362421.001]
  • [Cites] Can J Oncol. 1995 Dec;5 Suppl 1:16-27 [8853520.001]
  • [Cites] Expert Opin Pharmacother. 2003 Apr;4(4):567-80 [12667119.001]
  • [Cites] Br J Cancer. 2003 Jul 7;89(1):178-84 [12838321.001]
  • [Cites] N Engl J Med. 1996 Dec 12;335(24):1785-91 [8965890.001]
  • [Cites] Skeletal Radiol. 1989;18(7):517-21 [2588030.001]
  • [Cites] Br J Cancer. 2000 Feb;82(4):858-64 [10732759.001]
  • (PMID = 17912514.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Bone Density Conservation Agents; 0 / Contrast Media; 0 / Diphosphonates; 0 / Imidazoles; 182ECH14UH / iobitridol; 4419T9MX03 / Iohexol; 6XC1PAD3KF / zoledronic acid
  •  go-up   go-down


2. Martin RC, Scoggins CR, McMasters KM: Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol; 2007 Nov 1;96(6):481-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumor types, metastatic colorectal cancer (n = 9), hepatocellular (n = 5), metastatic carcinoid (n = 2), and one patient each with metastatic ovarian, breast, and gastric.
  • The overall ablation success at the discharge CT of the abdomen was 100%.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17654527.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


3. Islam T, Harisinghani MG: Overview of nanoparticle use in cancer imaging. Cancer Biomark; 2009;5(2):61-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overview of nanoparticle use in cancer imaging.
  • Current cross-sectional imaging modalities are inaccurate in characterizing nodal metastatic disease because of their use of size and/or morphology as differentiating factors.
  • Ferumoxtran-10-enhanced MRI offers higher diagnostic precision than unenhanced MRI and is sensitive and specific for the detection of lymph-node metastases, especially in malignant diseases of the abdomen and pelvis.

  • MedlinePlus Health Information. consumer health - Iron.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19414922.001).
  • [ISSN] 1574-0153
  • [Journal-full-title] Cancer biomarkers : section A of Disease markers
  • [ISO-abbreviation] Cancer Biomark
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Magnetite Nanoparticles; 0 / Oxides; 0 / ferumoxtran-10; E1UOL152H7 / Iron; K3R6ZDH4DU / Dextrans; XM0M87F357 / Ferrosoferric Oxide
  • [Number-of-references] 57
  •  go-up   go-down


Advertisement
4. Lee DK: Prostate cancer metastases to the leg, ankle, and foot. J Am Podiatr Med Assoc; 2008 May-Jun;98(3):242-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prostate cancer metastases to the leg, ankle, and foot.
  • Metastases to the bones of the lower extremities from prostate carcinomas are rare and are usually associated with diffuse metastatic disease or primary tumors of the abdomen and lungs.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18487599.001).
  • [ISSN] 8750-7315
  • [Journal-full-title] Journal of the American Podiatric Medical Association
  • [ISO-abbreviation] J Am Podiatr Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Ambika S, Melton A, Lee D, Hesketh PJ: Massive retroperitoneal adrenal hemorrhage secondary to lung cancer metastasis treated by adrenal artery embolization. Clin Lung Cancer; 2009 Sep;10(5):E1-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Massive retroperitoneal adrenal hemorrhage secondary to lung cancer metastasis treated by adrenal artery embolization.
  • The development of adrenal hemorrhage from lung cancer metastasis is extremely rare.
  • A 54-year-old woman with stage IV non-small-cell lung cancer and known bilateral adrenal metastasis developed severe right-sided abdominal pain while undergoing chemotherapy treatment.
  • A computerized tomography scan of the abdomen with intravenous contrast demonstrated massive right-sided retroperitoneal hemorrhage.
  • TCE can be used to control hemorrhage arising from metastatic involvement of the adrenal gland.


6. Syryło T, Syryło A, Jurkiewicz D, Zieliński H, Pietka T: An upper lip tumour as the presenting symptom of metastatic renal cancer. Otolaryngol Pol; 2010 Sep-Oct;64(5):318-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An upper lip tumour as the presenting symptom of metastatic renal cancer.
  • Unfortunately, in spite of continuous development of more and more efficient diagnostic methods, in about 30% of patients with RCC metastatic spread is found at presentation.
  • We present a case of a male patient in whom a tumour of the upper lip was the first symptom of advanced renal cancer.
  • A CT scan of the chest and abdomen showed a large tumour of the kidney, multiple lung and bone metastases.
  • CONCLUSIONS: In natural history of renal cancer there is a risk of metastatic spread to the head-and-neck region.
  • Contrast enhanced computed tomography of the abdomen should be considered if a tumour of unknown origin is found within the head-and-neck region.
  • Prognosis in case of confirmed metastatic renal cancer is unfavourable and patient's treatment should be conducted in specialist centres.

  • Genetic Alliance. consumer health - Kidney cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21162343.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


7. Lim KH, Lee KW, Kim JH, Park SY, Choi SH, Lee JS: Anaplastic thyroid carcinoma initially presented with abdominal cutaneous mass and hyperthyroidism. Korean J Intern Med; 2010 Dec;25(4):450-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathological examination of the thyroid mass was compatible with anaplastic thyroid carcinoma (ATC) and the abdominal cutaneous mass was shown to be metastatic ATC.
  • [MeSH-minor] Abdomen. Female. Humans. Middle Aged. Thyroid Carcinoma, Anaplastic. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Hyperthyroidism.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Endocrinol (Oxf). 2002 Apr;56(4):553-5 [11966749.001]
  • [Cites] J Clin Pathol. 2004 Apr;57(4):435-8 [15047753.001]
  • [Cites] Thyroid. 2004 Mar;14(3):227-30 [15072705.001]
  • [Cites] J Indian Med Assoc. 1967 Sep 16;49(6):286 passim [5594025.001]
  • [Cites] Am J Surg. 1978 Oct;136(4):445-9 [707723.001]
  • [Cites] Am J Med. 1983 Oct;75(4):702-4 [6624779.001]
  • [Cites] J Endocrinol Invest. 1987 Jun;10(3):303-10 [3624802.001]
  • [Cites] Endocrinol Jpn. 1989 Dec;36(6):905-7 [2633916.001]
  • [Cites] Cancer. 1990 Jul 15;66(2):321-30 [1695118.001]
  • [Cites] Head Neck. 1995 Jan-Feb;17(1):41-7; discussion 47-8 [7883548.001]
  • [Cites] Cancer. 1997 Feb 1;79(3):564-73 [9028369.001]
  • [Cites] J Am Acad Dermatol. 1997 Apr;36(4):531-7 [9092737.001]
  • [Cites] Thyroid. 1998 Nov;8(11):1045-50 [9848721.001]
  • [Cites] Am J Dermatopathol. 2005 Aug;27(4):306-12 [16121050.001]
  • [Cites] Endocr Pathol. 2005 Fall;16(3):245-50 [16299408.001]
  • [Cites] J Laryngol Otol. 2007 Jul;121(7):695-7 [17156585.001]
  • [Cites] Thyroid. 1999 Oct;9(10):1029-32 [10560959.001]
  • [Cites] Thyroid. 2000 Jul;10(7):587-94 [10958311.001]
  • [Cites] Biomed Pharmacother. 2001 Oct;55(8):466-74 [11686581.001]
  • [Cites] Surgery. 2001 Dec;130(6):1028-34 [11742333.001]
  • (PMID = 21179285.001).
  • [ISSN] 1226-3303
  • [Journal-full-title] The Korean journal of internal medicine
  • [ISO-abbreviation] Korean J. Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2997976
  • [Keywords] NOTNLM ; Anaplastic carcinoma / Cutaneous metastasis / Hyperthyroidism / Thyroid neoplasms
  •  go-up   go-down


8. Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B: A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol; 2008 Mar;179(3):906-10; discussion 910
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.
  • PURPOSE: Managing biochemical failure in patients following initial treatment of localized prostate cancer is a relatively common clinical problem.
  • Imaging studies to document metastatic disease are frequently obtained but are often uninformative.
  • MATERIALS AND METHODS: From CaPSURE, a national disease registry, all patients with a detectable prostate specific antigen after definitive therapy with radical prostatectomy or radiation therapy and who had undergone at least 1 imaging study (bone scan, computerized tomography or magnetic resonance imaging of the abdomen and pelvis) were identified.


9. Gencosmanoglu R, Aker F, Kir G, Tozun N: Isolated metachronous splenic metastasis from synchronous colon cancer. World J Surg Oncol; 2006;4:42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated metachronous splenic metastasis from synchronous colon cancer.
  • BACKGROUND: Isolated splenic metastases from colorectal cancer are very rare and there are only 13 cases reported in the English literature so far.
  • However, a gradually rising CEA level after the 14th postoperative month necessitated further imaging studies including computed tomography of the abdomen which revealed a mass in the spleen that was subsequently confirmed by 18FDG- PET scanning to be an isolated metastasis.
  • The patient underwent splenectomy 17 months after his previous cancer surgery.
  • Histological diagnosis confirmed a metastatic adenocarcinoma with no capsule invasion.
  • CONCLUSION: Isolated splenic metastasis is a rare finding in the follow-up of colorectal cancer patients and long-term survival can be achieved with splenectomy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Surg Oncol. 1993 Oct;19(5):485-90 [8405487.001]
  • [Cites] Clin Nucl Med. 1982 Jan;7(1):5-7 [7060295.001]
  • [Cites] South Med J. 1997 Jun;90(6):633-6 [9191741.001]
  • [Cites] Br J Surg. 1997 Jan;84(1):70 [9043458.001]
  • [Cites] Dis Colon Rectum. 1999 Oct;42(10):1345-8 [10528777.001]
  • [Cites] J Korean Med Sci. 2000 Jun;15(3):355-8 [10895982.001]
  • [Cites] Mayo Clin Proc. 1969 Jan;44(1):40-5 [5767148.001]
  • [Cites] Am J Clin Oncol. 2001 Jun;24(3):311-2 [11404507.001]
  • [Cites] Jpn J Clin Oncol. 2001 Jul;31(7):341-5 [11518749.001]
  • [Cites] South Med J. 1992 Oct;85(10):1003-5 [1411716.001]
  • [Cites] J Exp Clin Cancer Res. 2004 Mar;23(1):143-6 [15149163.001]
  • [Cites] Am J Med. 1979 Feb;66(2):311-20 [371397.001]
  • [Cites] Clin Nucl Med. 1986 Jul;11(7):491-2 [3731648.001]
  • [Cites] Am Surg. 2001 May;67(5):454-7 [11379648.001]
  • (PMID = 16824207.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1526733
  •  go-up   go-down


10. Sawyer A, McGoldrick RB, Mackey SP, Allan R, Powell B: Does staging computered tomography change management in thick malignant melanoma? J Plast Reconstr Aesthet Surg; 2009 Apr;62(4):453-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Currently UK guidelines for the management of cutaneous melanoma at intermediate or high risk of recurrent disease (American Joint Cancer Committee) AJCC IIB disease or worse (Breslow 2.01-4.0mm with ulceration or Breslow >4mm) should have the following staging investigations: chest X-ray; liver ultrasonography or computed tomographic (CT) scan with intravenous contrast enhancement of chest, abdomen and pelvis; liver function tests; lactate dehydrogenase and full blood count.
  • All of these patients exhibited symptoms and signs of clinical metastatic disease.
  • Head metastases are at least as common as other regions such as the chest & abdomen and more common than in the pelvis.
  • CONCLUSION: CT staging for cutaneous melanoma is not indicated unless there are signs or symptoms of metastatic disease.
  • If there are symptoms and signs of metastatic disease than patients should be staged and we advocate that staging of AJCC IIB/C should include imaging of the head in addition to chest, abdomen and pelvis.

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18468970.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


11. Kosmider S, Stella DL, Field K, Moore M, Ananda S, Oakman C, Singh M, Gibbs P: Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice? Colorectal Dis; 2009 Jul;11(6):592-600
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice?
  • CT abdomen/pelvis was performed in 222 (86%) of cases, ranging from 69% to 98% per centre.
  • In 17 cases (18%) CT chest examinations revealed abnormalities suspicious for metastatic disease, leading to a change in management in six (35%) of these cases.

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18624816.001).
  • [ISSN] 1463-1318
  • [Journal-full-title] Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
  • [ISO-abbreviation] Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen
  •  go-up   go-down


12. Fiore D, Baggio V, Ruol A, Bocus P, Casara D, Corti L, Muzzio PC: Multimodal imaging of esophagus and cardia cancer before and after treatment. Radiol Med; 2006 Sep;111(6):804-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multimodal imaging of esophagus and cardia cancer before and after treatment.
  • PURPOSE: Prognosis and treatment of esophagus and cardia cancer (ECC) depend on the precision with which the disease is staged according to the American Joint Committee of Cancer (AJCC) criteria.
  • MATERIALS AND METHODS: Fifty-six patients with ECC diagnosed by X-ray of the upper digestive tract, endoscopy and biopsy were staged using EUS, chest and abdomen CT scan, and CT-PET.
  • In the 52 patients who had surgery, follow-up included digestive tract X-ray, endoscopy and CT of the chest and abdomen every 6-8 months for the first 3 years.
  • Only CT-PET revealed metastatic subdiaphragmatic lymph nodes (diameter <15 mm) in three cases.
  • Presurgical restaging of the 18 patients (stage III) who had chemotherapy was based on endoscopy, EUS, CT of the chest and abdomen and CT-PET (only in suspected cases) and was compatible with surgery.
  • CONCLUSIONS: X-ray of the upper digestive tract and chest and abdomen CT scan are useful in preliminary evaluation of ECC.
  • CT-PET is extremely useful in identifying small mediastinal metastatic lymph nodes (N1) or extrathoracic lymph nodes (M1) and hepatic metastases (</=1 cm), which may escape multislice CT.

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16896560.001).
  • [ISSN] 0033-8362
  • [Journal-full-title] La Radiologia medica
  • [ISO-abbreviation] Radiol Med
  • [Language] eng; ita
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


13. Glasgow CG, Taveira-DaSilva A, Pacheco-Rodriguez G, Steagall WK, Tsukada K, Cai X, El-Chemaly S, Moss J: Involvement of lymphatics in lymphangioleiomyomatosis. Lymphat Res Biol; 2009 Dec;7(4):221-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lymphangioleiomyomatosis (LAM), a rare multisystem disease, occurs primarily in women, with cystic destruction of the lungs, abdominal tumors, and involvement of the axial lymphatics in the thorax and abdomen.
  • Consistent with their metastatic behavior, LAM cells were isolated from blood, urine, and chylous effusions.
  • Surface proteins on LAM cells include those found on metastatic cells and those involved in cell migration.
  • LAM cell clusters have been isolated from chylous pleural effusions, and it is hypothesized that these clusters may be responsible for metastatic spread of LAM cells via lymphatic vessels.

  • Genetic Alliance. consumer health - Lymphangioleiomyomatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thorax. 2004 Sep;59(9):800-3 [15333859.001]
  • [Cites] Cancer. 1973 Apr;31(4):988-1007 [4706060.001]
  • [Cites] Am J Pathol. 1975 May;79(2):348-82 [1146965.001]
  • [Cites] Cancer. 1976 Dec;38(6):2357-66 [1000470.001]
  • [Cites] J Biol Chem. 2002 Aug 23;277(34):30958-67 [12045200.001]
  • [Cites] Am J Respir Crit Care Med. 2002 Sep 1;166(5):765-73 [12204879.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6 [12271141.001]
  • [Cites] Hum Pathol. 2003 Jan;34(1):95-8 [12605373.001]
  • [Cites] Am J Respir Cell Mol Biol. 2003 Apr;28(4):504-11 [12654640.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Apr 1;167(7):976-82 [12411287.001]
  • [Cites] Am J Respir Cell Mol Biol. 2003 May;28(5):546-50 [12707009.001]
  • [Cites] Curr Biol. 2003 Aug 5;13(15):1259-68 [12906785.001]
  • [Cites] Cancer Cell. 2003 Aug;4(2):147-58 [12957289.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Dec 15;168(12):1427-31 [12958050.001]
  • [Cites] Arch Pathol Lab Med. 2000 Feb;124(2):267-75 [10656737.001]
  • [Cites] Radiology. 2000 Feb;214(2):441-6 [10671592.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 May 23;97(11):6085-90 [10823953.001]
  • [Cites] Mayo Clin Proc. 2000 Jun;75(6):591-4 [10852420.001]
  • [Cites] Radiology. 2000 Jul;216(1):147-53 [10887241.001]
  • [Cites] J Nippon Med Sch. 2000 Oct;67(5):311-29 [11031360.001]
  • [Cites] Hum Pathol. 2000 Oct;31(10):1242-8 [11070117.001]
  • [Cites] Arch Pathol Lab Med. 2000 Nov;124(11):1642-8 [11079017.001]
  • [Cites] Thorax. 2000 Dec;55(12):1052-7 [11083892.001]
  • [Cites] Acta Cytol. 2000 Nov-Dec;44(6):1081-4 [11127739.001]
  • [Cites] Am J Med Sci. 2001 Jan;321(1):17-25 [11202475.001]
  • [Cites] Am J Surg Pathol. 2001 Apr;25(4):479-84 [11257622.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Aug 15;164(4):661-8 [11520734.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Aug 15;164(4):669-71 [11520735.001]
  • [Cites] J Investig Med. 2001 Sep;49(5):421-33 [11523698.001]
  • [Cites] J Cutan Pathol. 2001 Oct;28(9):470-5 [11553313.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Sep 15;164(6):1072-6 [11587999.001]
  • [Cites] Radiology. 2001 Nov;221(2):415-21 [11687685.001]
  • [Cites] Respir Res. 2001;2(1):10-9 [11686860.001]
  • [Cites] J Hum Genet. 2002;47(1):20-8 [11829138.001]
  • [Cites] J Am Acad Dermatol. 2002 Mar;46(3):376-80 [11862172.001]
  • [Cites] FASEB J. 2002 Jul;16(9):922-34 [12087053.001]
  • [Cites] Physiol Rev. 2002 Jul;82(3):673-700 [12087132.001]
  • [Cites] Am J Surg Pathol. 2004 Aug;28(8):1007-16 [15252306.001]
  • [Cites] Kidney Int. 2004 Sep;66(3):924-34 [15327383.001]
  • [Cites] J Cutan Pathol. 1981 Dec;8(6):395-403 [6278000.001]
  • [Cites] Ann N Y Acad Sci. 1991;615:125-7 [2039137.001]
  • [Cites] Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):527-33 [7842216.001]
  • [Cites] Hum Mol Genet. 1994;3 Spec No:1477-80 [7849741.001]
  • [Cites] Eur Respir J. 1996 Mar;9(3):402-5 [8729995.001]
  • [Cites] Br J Dermatol. 1996 Jul;135(1):1-5 [8776349.001]
  • [Cites] Acta Cytol. 1997 Mar-Apr;41(2):522-8 [9100792.001]
  • [Cites] Hum Pathol. 1997 Sep;28(9):1071-8 [9308732.001]
  • [Cites] Am J Hum Genet. 1998 Apr;62(4):810-5 [9529362.001]
  • [Cites] Chest. 1999 Apr;115(4):1041-52 [10208206.001]
  • [Cites] Am J Respir Cell Mol Biol. 1999 Sep;21(3):327-36 [10460750.001]
  • [Cites] Medicine (Baltimore). 1999 Sep;78(5):321-37 [10499073.001]
  • [Cites] Chest. 2004 Dec;126(6):1867-74 [15596686.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17462-7 [15583138.001]
  • [Cites] AJR Am J Roentgenol. 2005 Feb;184(2):459-64 [15671364.001]
  • [Cites] J Exp Med. 2005 Sep 5;202(5):617-24 [16129702.001]
  • [Cites] Am J Surg Pathol. 2005 Oct;29(10):1356-66 [16160479.001]
  • [Cites] Am J Respir Crit Care Med. 2006 Jan 1;173(1):105-11 [16210669.001]
  • [Cites] Am J Respir Cell Mol Biol. 2006 Jul;35(1):40-7 [16474096.001]
  • [Cites] Lymphat Res Biol. 2006;4(3):143-52 [17034294.001]
  • [Cites] Cancer Control. 2006 Oct;13(4):276-85 [17075565.001]
  • [Cites] Radiology. 2007 Jan;242(1):277-85 [17105849.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L800-8 [17616646.001]
  • [Cites] Cancer Res. 2007 Nov 1;67(21):10573-81 [17975002.001]
  • [Cites] Chest. 2007 Nov;132(5):1573-8 [17890459.001]
  • [Cites] N Engl J Med. 2008 Jan 10;358(2):140-51 [18184959.001]
  • [Cites] N Engl J Med. 2008 Jan 10;358(2):199-200 [18184970.001]
  • [Cites] Chest. 2008 Feb;133(2):507-16 [18252917.001]
  • [Cites] J Immunol. 2009 Feb 1;182(3):1270-7 [19155472.001]
  • [Cites] Chest. 2009 May;135(5):1293-300 [19420197.001]
  • [Cites] Chest. 2009 Dec;136(6):1596-603 [19447921.001]
  • (PMID = 20143921.001).
  • [ISSN] 1557-8585
  • [Journal-full-title] Lymphatic research and biology
  • [ISO-abbreviation] Lymphat Res Biol
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Vascular Endothelial Growth Factor D
  • [Other-IDs] NLM/ PMC2883505
  •  go-up   go-down


14. Dietrich CF, Braden B, Hocke M, Ott M, Ignee A: Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol; 2008 Jun;134(6):635-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS AND METHODS: A total of 112 solitary undetermined pancreatic masses (70 ductal adenocarcinoma and 42 neoplastic nodules of other origin) were prospectively examined in patients without metastatic disease using transabdominal ultrasound.
  • [MeSH-major] Abdomen / diagnostic imaging. Pancreatic Neoplasms / diagnostic imaging

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] J Cancer Res Clin Oncol. 2008 Jun;134(6):723
  • [Cites] Eur J Radiol. 2001 May;38(2):94-104 [11335091.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1999 Jul;11(7):747-53 [10445795.001]
  • [Cites] J Ultrasound Med. 2004 Dec;23 (12 ):1557-68 [15557299.001]
  • [Cites] World J Gastroenterol. 2006 Jan 14;12 (2):246-50 [16482625.001]
  • [Cites] Radiology. 1974 Aug;112(2):275-82 [4835020.001]
  • [Cites] Pancreas. 2003 Jan;26(1):76-81 [12499921.001]
  • [Cites] J Ultrasound Med. 2005 Jun;24(6):849-54 [15914689.001]
  • [Cites] World J Gastroenterol. 2006 Jul 14;12 (26):4181-4 [16830370.001]
  • [Cites] J Am Coll Surg. 1994 Dec;179(6):747-57 [7952490.001]
  • [Cites] Pancreas. 2004 Apr;28(3):335-43 [15084983.001]
  • [Cites] Semin Diagn Pathol. 2004 Nov;21(4):260-7 [16273945.001]
  • [Cites] AJR Am J Roentgenol. 1997 Nov;169(5):1263-7 [9353439.001]
  • [Cites] Hepatology. 1997 Aug;26(2):467-72 [9252160.001]
  • [Cites] Cancer Imaging. 2006 Dec 20;6:199-203 [17208676.001]
  • [Cites] Am J Gastroenterol. 1998 Apr;93(4):632-5 [9576461.001]
  • [Cites] AJR Am J Roentgenol. 2002 Nov;179(5):1273-9 [12388513.001]
  • [Cites] World J Gastroenterol. 2006 Mar 21;12(11):1699-705 [16586537.001]
  • [Cites] Cancer. 2005 Mar 1;103(5):1026-35 [15672386.001]
  • [Cites] Radiology. 1999 Jul;212(1):213-8 [10405744.001]
  • [Cites] Am J Gastroenterol. 2005 Jan;100(1):144-52 [15654794.001]
  • [Cites] Nihon Rinsho. 1998 Apr;56(4):1024-9 [9577628.001]
  • [Cites] Gut. 2004 Mar;53(3):401-5 [14960524.001]
  • [Cites] Radiology. 2006 Nov;241(2):441-8 [16982815.001]
  • [Cites] Gut. 2005 Jul;54(7):1047 [15951559.001]
  • [Cites] JOP. 2006 Nov 10;7(6):584-92 [17095837.001]
  • [Cites] Ultraschall Med. 2005 Aug;26(4):277-84 [16123921.001]
  • [Cites] J Ultrasound Med. 2002 Apr;21(4):409-16; quiz 417 [11934098.001]
  • [Cites] J Gastroenterol. 2005 Jun;40(6):631-40 [16007398.001]
  • [Cites] J Ultrasound Med. 2003 Aug;22(8):789-95 [12901406.001]
  • [Cites] J Gastroenterol. 2005 Jun;40(6):666-8 [16007407.001]
  • [Cites] Z Gastroenterol. 2004 Apr;42(4):317-21 [15095122.001]
  • [Cites] J Gastroenterol. 2005 May;40(5):518-25 [15942718.001]
  • [Cites] AJR Am J Roentgenol. 2002 May;178(5):1133-7 [11959716.001]
  • [Cites] Gut. 2004 Jun;53(6):854-9 [15138213.001]
  • [Cites] J Ultrasound Med. 2004 Aug;23 (8):1125-9 [15284474.001]
  • [Cites] Pancreatology. 2005;5(4-5):398-402 [15985763.001]
  • (PMID = 17952469.001).
  • [ISSN] 0171-5216
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


15. Park JM, Kim DS, Oh SH, Kwon YS, Lee KH: A case of esophageal adenocarcinoma metastasized to the scalp. Ann Dermatol; 2009 May;21(2):164-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lung, breast, and colorectal cancers are common primary tumors that metastasize to the skin; cutaneous metastasis usually occurs on the chest wall and abdomen as asymptomatic nodular patterns.
  • Esophageal cancer is not nearly as common as breast, lung, and colorectal cancers, and esophageal cancer rarely metastasizes to the skin.
  • Cutaneous metastasis of esophageal cancer is rare and metastasis to the scalp is extremely rare.
  • Only a few cases of cutaneous metastases of esophageal cancer have been reported in Korea.
  • Herein, we describe a case of metastatic skin cancer that originated from esophageal adenocarcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gastroenterol Hepatol. 2007 Jun;22(6):908-12 [17565647.001]
  • [Cites] Gastroenterologist. 1997 Dec;5(4):278-94 [9436004.001]
  • [Cites] Gastroenterology. 1993 Feb;104(2):510-3 [8425693.001]
  • [Cites] Cutis. 1987 Feb;39(2):119-21 [3829718.001]
  • [Cites] J Am Acad Dermatol. 1990 Jan;22(1):19-26 [2298962.001]
  • [Cites] J Cutan Pathol. 2004 Jul;31(6):419-30 [15186430.001]
  • [Cites] Hum Pathol. 1999 Mar;30(3):288-94 [10088547.001]
  • [Cites] J Cutan Pathol. 2001 Sep;28(8):425-31 [11493381.001]
  • [Cites] Cancer. 1995 Oct 1;76(7):1120-5 [8630886.001]
  • [Cites] J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):161-82; quiz 183-6 [7622642.001]
  • [Cites] J Am Acad Dermatol. 1993 Aug;29(2 Pt 1):228-36 [8335743.001]
  • [Cites] J Am Acad Dermatol. 1993 Jan;28(1):1-13 [8425947.001]
  • [Cites] Mod Pathol. 2002 Jun;15(6):611-6 [12065774.001]
  • [Cites] Ann Dermatol Venereol. 2001 Dec;128(12):1310-5 [11908133.001]
  • [Cites] J Clin Ultrasound. 2007 Jun;35(5):289-92 [17366561.001]
  • (PMID = 20523777.001).
  • [ISSN] 2005-3894
  • [Journal-full-title] Annals of dermatology
  • [ISO-abbreviation] Ann Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2861207
  • [Keywords] NOTNLM ; Adenocarcinoma / Esophagus / Metastasis / Scalp
  •  go-up   go-down


16. Giannakis D, Tsili AC, Zioga A, Tsampoulas K, Sofikitis N: Early-stage sarcomatoid renal cell carcinoma: multidetector CT findings. Urol Int; 2009;82(3):367-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 64-year-old woman was referred for multidetector CT examination of the abdomen due to an incidental right renal mass, found on routine sonographic examination.
  • A lower pole renal mass was detected on CT, with no signs of invasiveness or metastatic disease.
  • [MeSH-minor] Biopsy. Early Detection of Cancer. Female. Humans. Incidental Findings. Middle Aged. Neoplasm Staging. Nephrectomy. Treatment Outcome

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 S. Karger AG, Basel.
  • (PMID = 19440031.001).
  • [ISSN] 1423-0399
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


17. Stroszczynski C, Jost D, Reichardt P, Chmelik P, Gaffke G, Kretzschmar A, Schneider U, Felix R, Hohenberger P: Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI. Eur Radiol; 2005 Dec;15(12):2448-56
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MRI was performed in 45 patients (25 responders, 20 non-responders) with metastatic or locally advanced, unresectable GIST.
  • [MeSH-major] Abdomen / pathology. Gastrointestinal Stromal Tumors / drug therapy. Gastrointestinal Stromal Tumors / pathology. Magnetic Resonance Imaging / methods. Piperazines / therapeutic use. Pyrimidines / therapeutic use


18. Petrović D, Muzikravić L, Jovanović D: [Metastases of unknown origin--principles of diagnosis and treatment]. Med Pregl; 2007 Jan-Feb;60(1-2):29-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DEFINITION: Cancer of unknown primary (CUP) origin refers to patients who present with histologicaly confirmed metastatic cancer in whom a detailed medical history, complete physical examination, including pelvic and rectal examination, full blood count and biochemistry, urinalysis and stool occult blood testing, hisinpathological review oJ biopsy speimens with the use of immunohistochemistry, chest radiography, computed tomography of the abdomen and pelvis, and in certain cases mammography, fail to identify the primary site.
  • EPIDEMIOLOGY OF CUP: The cancer of unknown primary accounts for 3%-5% of all human cancers.
  • DIAGNOSIS OF CUP: The standard diagnostic procedure for the majority of patients includes histopathologic review of biopsy specimens with the use of immunoltistochemistry, chest radiography, computed tomography of the abdomen and pelvis, and in certain cases mamography, fail to identify the abdomen and pelvis.
  • CONCLUSION: Metastatic tumors of unknown origin have a unique clinical presentation due to a specific biology.

  • Genetic Alliance. consumer health - Diagnosis Unknown.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17853708.001).
  • [ISSN] 0025-8105
  • [Journal-full-title] Medicinski pregled
  • [ISO-abbreviation] Med. Pregl.
  • [Language] srp
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Serbia and Montenegro
  • [Number-of-references] 41
  •  go-up   go-down


19. Pouessel D, Thezenas S, Culine S, Becht C, Senesse P, Ychou M: Hepatic metastases from carcinomas of unknown primary site. Gastroenterol Clin Biol; 2005 Dec;29(12):1224-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: One hundred and eighteen patients were treated at the Cancer Center of Montpellier from 1993 to 2002 for CUP initially metastatic to the liver.
  • Hepatic metastases revealed the cancer in 66 patients and were isolated in 32 patients.
  • Other metastatic sites involved lymph nodes, lung and bone.
  • Pretreatment computed tomography scans of the chest, abdomen and pelvis evaluation were available for more than 80% of patients.

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16518276.001).
  • [ISSN] 0399-8320
  • [Journal-full-title] Gastroentérologie clinique et biologique
  • [ISO-abbreviation] Gastroenterol. Clin. Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] EC 1.1.1.27 / L-Lactate Dehydrogenase
  •  go-up   go-down


20. Chen JH, Chang PY, Ho CL, Chen YC, Kao WY: Retroperitoneal metastatic adenocarcinoma complicated with necrotizing fasciitis of the thigh in a patient with advanced rectal colon cancer. Case Rep Oncol; 2010;3(2):304-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal metastatic adenocarcinoma complicated with necrotizing fasciitis of the thigh in a patient with advanced rectal colon cancer.
  • BACKGROUND: Necrotizing fasciitis of the thigh due to colon cancer has not been previously reported, especially during radiotherapy.
  • CASE PRESENTATION: A 73-year-old woman admitted to our hospital was diagnosed with sigmoid colon cancer that had spread to the left psoas muscle; radiotherapy was performed.
  • Computed tomography of the abdomen revealed fluid and gas tracking from the retroperitoneum into the intramuscular plane of the grossly enlarged right thigh.
  • CONCLUSION: Necrotizing fasciitis of the thigh due to the spread of rectal colon cancer is unusual, but this fatal complication should be considered during radiotherapy in patients with unresectable colorectal cancer.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Surg. 2006;6:11 [17010190.001]
  • [Cites] Am J Emerg Med. 1999 Oct;17(6):594-6 [10530543.001]
  • [Cites] J Emerg Med. 2006 Jan;30(1):95-6 [16434345.001]
  • [Cites] Bull Hosp Jt Dis. 1996;55(2):83-5 [8879743.001]
  • [Cites] World J Surg Oncol. 2009;7:74 [19811627.001]
  • [Cites] J Plast Reconstr Aesthet Surg. 2009 Feb;62(2):e17-9 [18316255.001]
  • [Cites] World J Gastroenterol. 2006 Aug 28;12(32):5256-8 [16937546.001]
  • [Cites] Br J Surg. 2000 Jun;87(6):718-28 [10848848.001]
  • [Cites] Ann Surg Oncol. 2007 Jun;14(6):1860-9 [17356952.001]
  • [Cites] Clin Dermatol. 2005 Mar-Apr;23(2):144-7 [15802207.001]
  • [Cites] Mt Sinai J Med. 2001 Sep-Oct;68(4-5):253-61 [11514912.001]
  • (PMID = 21347198.001).
  • [ISSN] 1662-6575
  • [Journal-full-title] Case reports in oncology
  • [ISO-abbreviation] Case Rep Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Other-IDs] NLM/ PMC3042024
  • [Keywords] NOTNLM ; Colon cancer / Necrotizing fasciitis / Retroperitoneal
  •  go-up   go-down


21. Alaggio R, Cecchetto G, Bisogno G, Gambini C, Calabrò ML, Inserra A, Boldrini R, De Salvo GL, G d'Amore ES, Dall'igna P: Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies. Cancer; 2010 Jan 1;116(1):216-26
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Patients ages 8-216 months (median age, 60 months) presented with tumors of the lung-bronchus (8 patients), abdomen (17 patients), and thoracic wall (1 patient).
  • The results indicated that the treatment of choice is a complete, nonmutilating excision; chemotherapy may be given to patients who have microscopic or macroscopic residual disease, although the results are controversial; cytologic atypia and positive ALK status are more frequent in aggressive tumors, whereas metastatic tumors are negative for ALK; and HHV8 is not involved in the pathogenesis of IMT.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 American Cancer Society.
  • (PMID = 19852031.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / anaplastic lymphoma kinase
  •  go-up   go-down


22. Gold JS, Jaques DP, Busam KJ, Brady MS, Coit DG: Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy. Ann Surg Oncol; 2007 Jul;14(7):2133-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • At least one study (computed tomography or magnetic resonance imaging of the brain; chest x-ray; computed tomography of the thorax, abdomen, or pelvis; positron-emission tomography scan; or bone scan) was obtained around the time of SLNB in 178 patients (98%).
  • Among patients tested after SLNB, four were found to have metastatic disease (positive rate 3.7%).

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17453294.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Qi XP, Lin GB, Zhu YL, Wang JQ, Dai XW, Ma JM, Yan L: [Pseudoangiosarcomatous squamous cell carcinoma of the penis: a case report with clinicopathological and human papilloma virus analyses]. Zhonghua Nan Ke Xue; 2009 Feb;15(2):134-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CT scanning showed no enlarged lymph nodes in the abdomen and pelvis, and X-ray examination revealed no abnormality in the chest.
  • Under the light microsope, the tumor was mainly composed of vessel-like lacunar reticularis spindle cells and a few local squamous cancer cells.
  • HPV DNA (HPVpan, HPV6B/11, HPV16/18, HPV31/33) was not detected by in situ hybridization in the primary and metastatic tumors.


24. Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, Reiser MF, Hermann KA: Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol; 2009 Jun;19(6):1366-78
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
  • The purpose of this study was to assess the diagnostic accuracy of whole-body MRI (WB-MRI) at 1.5 T or 3 T compared with FDG-PET-CT in the follow-up of patients suffering from colorectal cancer.
  • In a retrospective study, 24 patients with a history of colorectal cancer and suspected tumour recurrence underwent FDG-PET-CT and WB-MRI with the use of parallel imaging (PAT) for follow-up.
  • High resolution coronal T1w-TSE and STIR sequences at four body levels, HASTE imaging of the lungs, contrast-enhanced T1w- and T2w-TSE sequences of the liver, brain, abdomen and pelvis were performed, using WB-MRI at either 1.5 T (n = 14) or 3 T (n = 10).
  • Presence of local recurrent tumour, lymph node involvement and distant metastatic disease was confirmed using radiological follow-up within at least 5 months as a standard of reference.
  • Initial results suggest that differences in accuracy for local and distant metastases detection using FDG-PET-CT and WB-MRI for integrated screening of tumour recurrence in colorectal cancer depend on the location of the malignant focus.


25. Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF, Schoenberg SO: Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol; 2008 Jan;65(1):47-58
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
  • PURPOSE: To compare the diagnostic accuracy for the detection of tumor recurrence in breast cancer patients using whole-body-MRI (WB-MRI) at 1.5 or 3T compared to FDG-PET-CT.
  • MATERIALS AND METHODS: Thirty-three female patients with breast cancer and suspicion of recurrence underwent FDG-PET-CT and WB-MRI.
  • Coronal T1w-TSE- and STIR-sequences, HASTE-imaging of the lungs, contrast-enhanced T1w- and T2w-TSE-sequences of the liver, brain and abdomen were performed, using a WB-MRI-scanner at 1.5 (n=23) or 3T (n=10).
  • Presence of local recurrence, lymph node involvement and distant metastatic disease was assessed using clinical and radiological follow-up as a standard of reference.
  • CONCLUSION: WB-MRI and PET-CT are useful for the detection of tumor recurrence in the follow-up of breast cancer.
  • WB-MRI is highly sensitive to distant metastatic disease.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18082989.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18; 4419T9MX03 / Iohexol; 712BAC33MZ / iopromide
  •  go-up   go-down


26. Musser JE, Przybycin CG, Russo P: Regression of metastatic seminoma in a patient referred for carcinoma of unknown primary origin. Nat Rev Urol; 2010 Aug;7(8):466-70